top of page
IMPACT Vector Logo FINAL-05.png

The IMPACT Team 

Learning How COVID-19 Affects Blood Cancer Risks

The IMPACT Study is run by a dedicated team of collaborators who develop new and

improved approaches to preventing and treating patients with early phases of blood cancers.    

By pooling their knowledge and resources, they're working together to make rapid progress, and move therapies and treatments from the laboratory to doctors’ offices, where they can benefit patients.

Research Leadership

Irene Ghobrial, MD Principal Investigator

Dana-Farber Cancer Institute

Irene Ghobrial, MD

Principal Investigator

Catherine Marinac, PhD Dana-Farber Cancer Institute

Catherine Marinac, PhD


Dana-Farber Cancer Institute

We're on a mission to stop blood cancer before it starts.  Join us!

bottom of page